Islet cell autoantibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study
2007

Autoantibodies in African Diabetes Patients

Sample size: 245 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lutale JJK, Thordarson H, Holm PI, Eide GE, Vetvik K

Primary Institution: Muhimbili University College of Health Sciences, Dar es Salaam, Tanzania

Hypothesis

What is the occurrence of glutamic acid decarboxylase and insulinoma antigen 2 autoantibodies among African patients with Type 1 and Type 2 diabetes?

Conclusion

The prevalence of GAD and IA2 autoantibodies among African patients with Type 1 diabetes in Dar es Salaam was much higher than previously reported for islet cell autoantibodies.

Supporting Evidence

  • 42.6% of patients with Type 1 diabetes had at least one positive autoantibody.
  • 28 (29.8%) of Type 1 diabetes patients were GADA positive.
  • 20 (21.3%) of Type 1 diabetes patients were IA2A positive.
  • Autoantibodies were detected more frequently in Type 1 diabetes than in Type 2 diabetes.

Takeaway

This study found that many African patients with Type 1 diabetes have specific autoantibodies that attack their insulin-producing cells, which is important for understanding their diabetes.

Methodology

A cross-sectional study measuring autoantibodies in 245 patients with Type 1 and Type 2 diabetes.

Potential Biases

Potential biases in patient selection and classification of diabetes types.

Limitations

The study may not be generalizable to all African populations due to its specific location and sample.

Participant Demographics

54.3% were women; median age at diagnosis for Type 1 was 17 years and for Type 2 was 48 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1740-2557-4-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication